Regenxbio (RGNX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

RGNX Regenxbio

Watchlist

12.580
-0.270-2.10%

Close Jul 19 16:00 ET

619.64MMarket Cap-2143P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

RBC Capital Remains a Buy on RegenXBio (RGNX)
TipRanks01:56 ET
Regenxbio (RGNX) Surges 18.3%: Is This an Indication of Further Gains?
Yahoo FinanceJul 12 09:59 ET
Here's Why Sarepta (SRPT) Stock Price Surged 57% YTD
Yahoo FinanceJul 8 12:04 ET
Regenxbio(RGNX.US) Director Sells US$112.69K in Common Stock
$Regenxbio(RGNX.US)$ Director KARABELAS ARGERIS N sold 10,000 shares of common stock on Jul 1, 2024 at an average price of $11.2691 for a total value of $112.69K.Source: Announcement What is statement
Moomoo NewsJul 3 08:38 ET
Why Did Analysts Maintain a Bullish Stance on REGENXBIO Inc. (RGNX) Despite Decline In Its Revenue Growth?
Yahoo FinanceJun 27 10:05 ET
Why Is Clearside Biomedical Stock Gaining Today?
Oppenheimer initiated coverage on Clearside Biomedical Inc (NASDAQ:CLSD), a biopharmaceutical company focused on delivering therapies to the back of the eye through the suprachoroidal (SCS) space.Oppe
BenzingaJun 25 12:54 ET

Comments

2F KILL CHEATERS

Mar 5 11:19

$Regenxbio(RGNX.US)$ SELL SELL SELL NOW EASY MONEY AND ENJOIN YOURS TAKE BREAK TOMORROW 💰💰💰😋😋😋🤩🤩🤩

Moomoo AI

Feb 17 07:06

Investors' pessimism about the company's revenue prospects may be causing the low P/S ratio. The company's forecast growth is lower than the wider industry, which could be contributing to the depressed P/S. It's hard to see the share price rising strongly in the near future given these circumstances.